Published in Clin Exp Immunol on June 01, 2001
The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest (2002) 1.15
Vitiligo--part 1. An Bras Dermatol (2014) 0.96
Nonsegmental vitiligo and autoimmune mechanism. Dermatol Res Pract (2011) 0.89
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A (1994) 6.93
New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry (1986) 5.12
A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc Natl Acad Sci U S A (1991) 1.97
The role of tyrosinase in autoimmune vitiligo. Lancet (1994) 1.66
Nucleotide sequence of the cDNA encoding human tyrosinase-related protein. Nucleic Acids Res (1990) 1.60
Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem (1994) 1.58
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol (1998) 1.41
Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol (1996) 1.31
Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochim Biophys Acta (1994) 1.22
Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol (1991) 1.15
Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line. Int J Cancer (1995) 1.06
Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol (1988) 1.02
Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol (1986) 0.97
Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100. Melanoma Res (1997) 0.97
Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo. J Invest Dermatol (1999) 0.96
Cloning and expression of the gene for the melanoma-associated ME20 antigen. DNA Cell Biol (1994) 0.95
Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol (1996) 0.95
Antibody responses to melanoma/melanocyte autoantigens in melanoma patients. J Invest Dermatol (1998) 0.95
Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol (1997) 0.93
Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol (1992) 0.92
Functional analysis of the cDNA encoding human tyrosinase precursor. Biochem Biophys Res Commun (1989) 0.92
Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA). Clin Exp Immunol (1998) 0.87
Autoimmune Addison's disease. Analysis of autoantibody binding sites on human steroid 21-hydroxylase. FEBS Lett (1993) 0.86
Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol (1983) 0.85
Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay. Thyroid (1999) 0.85
Methods of epitope mapping. Mol Biol Rep (1992) 0.80
A study of the epitopes on steroid 21-hydroxylase recognized by autoantibodies in patients with or without Addison's disease. Clin Exp Immunol (1998) 0.77
Association between Graves' ophthalmopathy and smoking. Lancet (1990) 2.62
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Autoimmune thyroid disease: developments in our understanding. Endocr Rev (1984) 1.98
Life-threatening arrhythmias and intravenous cimetidine. Br Med J (1979) 1.81
High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol (2001) 1.74
Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) (2002) 1.71
Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med (1986) 1.68
Nickel allergy following European Union regulation in Denmark, Germany, Italy and the U.K. Br J Dermatol (2013) 1.53
Use of a Giemsa stain to detect changes in acrosomes of frozen ram spermatozoa. Vet Rec (1975) 1.48
The immunomodulatory effects of antithyroid drugs. Thyroid (1994) 1.45
The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol (1994) 1.45
The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol (1994) 1.42
Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema. J Clin Endocrinol Metab (1995) 1.41
The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endocrinol Metab (1985) 1.40
Delayed and immediate orofacial reactions following contact with rubber gloves during dental treatment. Br Dent J (1996) 1.39
Thyroid antibodies are produced by thyroid-derived lymphocytes. Clin Exp Immunol (1982) 1.39
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Graves' disease by any other name? Thyroid (2000) 1.39
Is Graves' dermopathy a generalized disorder? Thyroid (1996) 1.39
Lichen planus is not commonly a skin marker of primary biliary cirrhosis. Dermatologica (1990) 1.37
Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol (2007) 1.34
The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol (1999) 1.34
Enzyme-linked immunoassay of monoclonal and serum microsomal autoantibodies. Clin Chim Acta (1984) 1.31
Autoimmune aspects of vitiligo. Autoimmunity (2001) 1.30
Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol (2006) 1.30
Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) (1997) 1.29
Dermatitis herpetiformis: diagnosis, diet and demography. Gut (1984) 1.28
Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol (2012) 1.24
Methimazole inhibits thyroid autoantibody production by an action on accessory cells. Clin Immunol Immunopathol (1983) 1.23
Sites of autoantibody production in rats with thyroiditis. Immunology (1982) 1.21
Prevention of osmotic injury to human spermatozoa during addition and removal of glycerol. Hum Reprod (1995) 1.20
The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology (1983) 1.19
The distribution and enteric loss of 51Cr-labelled lymphocytes in normal subjects and in patients with coeliac disease and other disorders of the small intestine. Digestion (1976) 1.18
Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol (1997) 1.17
Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf) (1994) 1.16
Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat. Clin Exp Immunol (1990) 1.16
Genetic and physiological analysis of azole sensitivity in Saccharomyces cerevisiae. J Med Vet Mycol (1989) 1.14
Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership. Br J Dermatol (2011) 1.10
A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) (1997) 1.10
Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis (2001) 1.10
Chinese herbs for eczema, the active compound? Lancet (1991) 1.10
The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis. Clin Immunol Immunopathol (1986) 1.10
Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart (1998) 1.09
Comparison of thyroid function in pregnant and non-pregnant Asian and western Caucasian women. Clin Chim Acta (2001) 1.09
Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole. Br Med J (Clin Res Ed) (1984) 1.08
How safe is patch testing to PPD? Br J Dermatol (2006) 1.08
Molecular genetic studies on the mode of action of azole antifungal agents. Biochem Soc Trans (1991) 1.08
Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J Clin Endocrinol Metab (2008) 1.07
IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol (1991) 1.06
Early cellular reactions induced by dinitrochlorobenzene in sensitized human skin. Br J Dermatol (1984) 1.06
HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) (1991) 1.06
An immunotoxin of ricin A chain conjugated to thyroglobulin selectively suppresses the antithyroglobulin autoantibody response. Lancet (1983) 1.04
Proceedings: Enteric loss of lymphocytes in coeliac disease and in Crohn's disease. Gut (1974) 1.04
Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol (1996) 1.03
Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol (1992) 1.03
The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. J Biol Chem (2001) 1.03
Determinants of autoimmune thyroid disease. Nat Immunol (2001) 1.02
Phenotypic characterization of the early cellular responses in allergic and irritant contact dermatitis. Clin Exp Immunol (1986) 1.02
The influence of cyclosporin a on experimental autoimmune thyroid disease in the rat. Life Sci (1983) 1.02
Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer. J Clin Endocrinol Metab (2000) 1.02
Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol (Oxf) (1984) 1.01
The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache (1993) 1.01
Immunological pathomechanisms in vitiligo. Expert Rev Mol Med (2001) 1.01
Asian women are at increased risk of gestational thyrotoxicosis. J Clin Endocrinol Metab (1996) 1.01
Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol (1997) 1.00
Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab (2000) 0.99
The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. Br J Dermatol (2008) 0.99
Survival of ram spermatozoa at high dilution: protective effect of simple constituents of culture media as compared with seminal plasma. Reprod Fertil Dev (1994) 0.99
A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab (2005) 0.98
Thyroid hormones fail to influence experimental autoimmune thyroiditis. Clin Exp Immunol (1982) 0.97
The pathogenesis of eosinophilic endomyocardial disease in patients with carcinomas of the lung. Heart Vessels (1985) 0.97
Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab (1995) 0.97
Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) (1996) 0.97
Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo. J Invest Dermatol (1999) 0.96
The IgG subclass distribution of thyroid autoantibodies. Immunol Lett (1986) 0.96
Regulation and tissue distribution of the human sodium iodide symporter gene. Clin Endocrinol (Oxf) (1998) 0.96
White sponge naevus successfully treated with topical tetracycline. Clin Exp Dermatol (1990) 0.96
Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab (1998) 0.95
IgG subclass distribution and relative functional affinity of anti-myeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up. Immunology (1991) 0.95
Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-gamma. Clin Immunol Immunopathol (1988) 0.95
Expression of apoptosis-related genes and proteins in experimental chronic renal scarring. J Am Soc Nephrol (2001) 0.95
The discrimination between nickel-sensitive and non-nickel-sensitive subjects by an in vitro lymphocyte transformation test. Br J Dermatol (1990) 0.94
Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. J Clin Endocrinol Metab (2003) 0.94
Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metab (1994) 0.94
The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol (Copenh) (1984) 0.93
Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol (1997) 0.93
Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod (1997) 0.93